deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT03508921

Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection

Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection: a Non-Inferiority Trial

Sponsor: Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction

Conditions Overactive Bladder Urinary Tract Infections
Interventions Extended Antibiotics Injection of OnabotulinumtoxinA (BTX-A) Periprocedural Antibiotics
Updated 12 times since 2018 Last updated: Oct 31, 2023 Started: Jul 1, 2018 Primary completion: Jun 1, 2022 Completion: Jun 1, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Early termination due to recruitment and follow-up challenges during the pandemic

Other Overactive Bladder trials with similar outcome

Browse all Overactive Bladder trials

A PHASE4 clinical study on Overactive Bladder and Urinary Tract Infections, this trial is terminated or withdrawn. The trial is conducted by Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction and has accumulated 12 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~May 2018 – ~Jun 2018 · 31 days · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotNot Yet Recruiting~Sep 2018 – ~Sep 2019 · 12 months · monthly snapshotRecruiting~Sep 2019 – ~Sep 2020 · 12 months · monthly snapshotRecruiting~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotRecruiting~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshotRecruiting~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshotRecruiting~Sep 2022 – ~Dec 2023 · 15 months · monthly snapshotCompleted~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotTerminated~Feb 2025 – present · 17 months · monthly snapshotTerminated

Change History

12 versions recorded

  1. Feb 2025 — Present [monthly]

    Terminated PHASE4

  2. Sep 2024 — Feb 2025 [monthly]

    Terminated PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  4. Dec 2023 — Jul 2024 [monthly]

    Terminated PHASE4

    Status: Completed → Terminated

  5. Sep 2022 — Dec 2023 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

▶ Show 7 earlier versions

  1. Sep 2021 — Sep 2022 [monthly]

    Recruiting PHASE4

  2. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE4

  3. Sep 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  4. Sep 2019 — Sep 2020 [monthly]

    Recruiting PHASE4

  5. Sep 2018 — Sep 2019 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  6. Jun 2018 — Sep 2018 [monthly]

    Not Yet Recruiting PHASE4

  7. May 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction
  • The Allergan Foundation
  • Vanderbilt University Medical Center
Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations